Vaping vs Oils vs Capsules: How to Take Medical Cannabis in the UK

Once you have received your medical cannabis prescription, the next question is how to use it safely and effectively. The method of administration has a significant impact on how quickly the medicine takes effect, how long it lasts and how precisely you can control your dose. This guide explains the three main routes — vaporisation, sublingual oil and capsules — along with practical guidance on titration and what to expect.

Vaporisation: Temperature, Technique and Medical-Grade Devices

Vaporisation is the most common method for dried cannabis flower prescriptions in the UK. Unlike smoking, vaporisation heats the flower to between 170 and 210 degrees Celsius — high enough to convert THCA and CBDA into their active forms, but below the combustion point of approximately 230 degrees. This produces a vapour rather than smoke, significantly reducing exposure to harmful combustion by-products.

Temperature matters: lower settings between 170 and 185 degrees favour terpene and CBD extraction, producing more clear-headed, functional effects. Higher settings between 195 and 210 degrees extract more THC and produce more sedative effects — more appropriate for evening or night-time use. Most patients start at around 185 degrees and adjust based on their response.

The MHRA does not licence vaporisers as medical devices, but UK clinicians commonly recommend two devices as de facto medical standards:

• Mighty+ (Storz and Bickel): A portable, battery-powered convection vaporiser with precise digital temperature control. Consistently rated as the most reliable device for medical use due to its even heat distribution and robust build quality.
• Volcano Medic 2 (Storz and Bickel): A desktop device used in clinical settings in several countries. Uses balloon bags to collect vapour, allowing very precise dosing and easy use for patients with limited dexterity. More expensive but highly accurate.

A typical starting dose with flower is one to two small draws of approximately 0.05 to 0.1 grams, waiting 15 to 20 minutes before assessing effect. You can compare prices across available flower products to find the most cost-effective option for your prescription.

Sublingual Oils and Capsules: Timing and Absorption

Cannabis oils prescribed in the UK are typically administered sublingually — placed under the tongue and held for 60 to 90 seconds before swallowing. The sublingual mucosa is rich in blood vessels, allowing cannabinoids to absorb directly into the bloodstream, bypassing first-pass hepatic metabolism. Onset is typically 15 to 45 minutes, with peak effects at 60 to 90 minutes and duration of four to six hours.

Key technique points for sublingual administration:

• Use the dropper or pipette to place oil under the tongue, not on top of it.
• Avoid eating or drinking for 15 minutes before and after — food can alter absorption.
• If the taste is unpleasant, hold briefly then swallow; some patients use a small amount of water after the hold period.

Capsules offer the most consistent dosing but the slowest onset — typically 45 to 90 minutes, with duration extending to six to eight hours. They are best suited for patients who need all-day background coverage and do not require rapid relief. The delayed onset means many patients underestimate the dose and re-dose too quickly; waiting the full 90 minutes before considering an additional dose is essential.

Titration: Finding Your Effective Dose

Titration is the process of starting with the lowest possible dose and slowly increasing until the desired therapeutic effect is achieved without unacceptable side effects. UK clinicians follow a start low, go slow principle, typically beginning patients at 2.5 to 5mg THC per session and increasing by 2.5mg every three to seven days.

Common side effects at higher doses include dry mouth, mild dizziness, increased heart rate, short-term memory impairment and, in some patients, anxiety. Most of these are dose-dependent and resolve by reducing the dose. Tolerance to sedative and psychoactive effects typically develops within two to four weeks of regular use.

Keeping a simple symptom and dose diary during the titration period is strongly recommended — your prescribing clinician will ask for this information at follow-up appointments. Most UK licensed clinics include a follow-up consultation within four to six weeks of starting a new prescription to review your response and adjust if necessary. Understanding your qualifying conditions and target symptoms makes titration more systematic and the outcome more predictable.